Artelo Biosciences Inc.
(ARTL)
undefined
undefined%
At close: undefined
1.11
0.00%
After-hours Dec 13, 2024, 06:21 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
Year | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 |
Net Income | -10.08M | -7.44M | -4.65M | -2.17M | -2.34M | -234.89K | -29.69K | -15.24K | -15.27K |
Depreciation & Amortization | - | - | 500.00 | 510.00 | 282.00 | 600.00 | - | - | - |
Stock-Based Compensation | 2.46M | 1.53M | 377.77K | 425.11K | 290.00K | 3.33K | - | - | - |
Other Working Capital | -195.00K | -239.00K | -169.26K | 40.39K | -57.51K | -1.50K | - | - | - |
Other Non-Cash Items | -211.00K | 7.00K | -29.50K | 100.00K | - | 600.00 | - | - | -14.73K |
Deferred Income Tax | - | - | - | -1.01M | - | -600 | - | - | - |
Change in Working Capital | -172.00K | -242.00K | -41.28K | -140.02K | 443.19K | 14.14K | 11.20K | 1.74K | 14.73K |
Operating Cash Flow | -8.01M | -6.14M | -4.35M | -2.79M | -1.61M | -216.82K | -18.49K | -13.50K | -15.27K |
Capital Expenditures | - | - | - | -1.50M | -845 | - | - | - | - |
Acquisitions | - | - | - | - | - | - | - | - | - |
Purchase of Investments | -13.22M | -3.44M | - | - | - | - | - | - | - |
Sales Maturities Of Investments | 16.18M | - | - | - | - | - | - | - | - |
Other Investing Acitivies | - | - | - | - | - | - | - | - | - |
Investing Cash Flow | 2.96M | -3.44M | - | -1.50M | -845 | - | - | - | - |
Debt Repayment | - | - | - | - | - | - | - | - | - |
Common Stock Repurchased | - | - | -108 | - | - | - | - | - | - |
Dividend Paid | - | - | - | - | - | - | - | - | - |
Other Financial Acitivies | - | 6.01M | 3.15K | 1.05K | 1.84K | 42.67K | 5.05K | - | - |
Financial Cash Flow | - | 14.11M | 1.98M | 8.38M | 1.39M | 785.35K | 5.05K | 15.80K | 30.00K |
Net Cash Flow | -5.27M | 4.49M | -2.28M | 4.09M | -235.35K | 569.18K | -13.44K | 2.30K | 14.73K |
Free Cash Flow | -8.01M | -6.14M | -4.35M | -4.29M | -1.61M | -216.82K | -18.49K | -13.50K | -15.27K |